Mindfulness Training Improved Positive Emotion Regulation in OUD
By Elana Gotkine HealthDay Reporter
THURSDAY, May 8, 2025 -- For patients with chronic pain, opioid use disorder (OUD) is characterized by difficulties in positive emotion regulation (ER), and mindfulness training can enhance positive ER, according to a study published online April 30 in JAMA Psychiatry.
Eric L. Garland, Ph.D., from the University of California in San Diego, and colleagues examined whether OUD is associated with attenuated positive ER in a randomized trial involving patients with chronic pain who did and did not meet criteria for OUD (OUD+ and OUD−, respectively). Participants at risk for opioid misuse were randomly allocated to receive eight weeks of Mindfulness-Oriented Recovery Enhancement (MORE) or supportive group (SG) therapy.
Overall, 98 of 160 participants using opioids were classified as OUD+. The researchers found a significant group-by-task strategy interaction during positive ER, with the OUD+ group exhibiting lower parietal late positive potential (LPP) responses during Regulate versus View trials compared with the OUD− group (B = 1.91). There was also a significant group-by-strategy interaction for the P300 amplitude during positive ER (B = 1.40). During positive ER, LPP blunting mediated the association between OUD status and elevated opioid craving. Compared with patients treated with SG, those treated with MORE showed greater increases in LPP during Regulate versus View trials (B = 1.53). Relative to SG, MORE improved attention to positive information, positive affect, and anhedonia (B = 1.32, 4.73, and 2.94, respectively) and reduced craving (B = −10.88) to a greater extent. Lower craving at follow-up was predicted by higher positive ER efficacy (B = −2.38).
“This study is a crucial step, but we need more large-scale and long-term research to fully understand how treatments like MORE can help heal the brain to enhance recovery from opioid addiction,” Garland said in a press release. “Multiple rigorous, well-controlled clinical trials have demonstrated the efficacy of the MORE therapy. It is now the right moment to partner with policymakers, health care organizations, and administrators of the opioid legal settlement to disseminate this evidence-based treatment nationwide to help alleviate the opioid crisis.”
One author received payments related to MORE and disclosed ties to BehaVR.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-05-09 06:00
Read more

- AACR: Incidence-Based Mortality Dropping for Young Women With Breast Cancer
- Screen Time in Bed Linked to Poorer Sleep Among Young Adults
- Mental Health, Neurodevelopmental Diagnoses in Publicly Insured Children on the Rise
- Lorundrostat Beneficial for BP Reduction in Uncontrolled Hypertension
- Emergency Department Visits for Asthma Increased During 2023 Wildfires
- Scalable Symptom Monitoring Intervention May Up Asthma-Related QoL in Subgroup of Adults
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions